Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Liabilities: 2009-2025

Historic Total Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $40.1 million.

  • Cumberland Pharmaceuticals' Total Liabilities fell 23.30% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 23.30%. This contributed to the annual value of $53.0 million for FY2024, which is 0.99% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Total Liabilities stood at $40.1 million, which was down 0.32% from $40.2 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Total Liabilities high stood at $57.0 million for Q4 2022, and its period low was $40.1 million during Q3 2025.
  • In the last 3 years, Cumberland Pharmaceuticals' Total Liabilities had a median value of $52.5 million in 2024 and averaged $49.5 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Total Liabilities soared by 36.06% in 2022, and later fell by 23.43% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Total Liabilities (Quarterly) stood at $41.9 million in 2021, then skyrocketed by 36.06% to $57.0 million in 2022, then decreased by 7.79% to $52.5 million in 2023, then rose by 0.99% to $53.0 million in 2024, then declined by 23.30% to $40.1 million in 2025.
  • Its Total Liabilities stands at $40.1 million for Q3 2025, versus $40.2 million for Q2 2025 and $41.6 million for Q1 2025.